Apothecary NAD+ Injection 200 mg/mL — Class II drug recall D-0037-2027
Ongoing recall by Apothecary Pharma LLC, reported 2026-10-14, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0037-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apothecary Pharma LLC, Cary, NC, United States |
| Recall initiated | 2026-09-24 |
| Classified | 2026-10-08 |
| Reported by FDA | 2026-10-14 |
| Distributed | Nationwide (US) |
| Quantity | 1 vials |
| Reason classes | sterility |
| NDC | 85091-0011-06 |
| Lot numbers | AP-202647 |
| Expiration dates | 2026-10-13 |
Product
Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0037-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.